Every fortnight, the world shifts a little more towards India. More and more global companies launch their India teams, new Pods, Capabilities & GCCs, AI roles multiply, and global businesses discover what we've known all along – India needs to be part of your solution stack, no matter who you are, what you do and where you are building.

The India Opportunity is our fortnightly insights publication that connects these dots for both companies (The what, why and how of making India work for you) and top talent (onground developments and insights to help you plan your next career move)!

OpenAI announced a multi-year deal with Cerebras worth over $10 billion on January 15, 2026, to receive 750 megawatts of dedicated compute capacity through 2028. The partnership aims to boost inference speed for OpenAI's products and resolve capacity constraints. The deal represents one of the largest compute commitments in AI infrastructure history and signals an acceleration in the "inference speed wars" as companies prioritize token-per-second performance over raw model size.​

The implication: Compute is becoming the new moat. For enterprises, this validates that 2026 is when inference cost and speed, not model capability, become competitive differentiators. Companies investing in proprietary compute (via partnerships like OpenAI-Cerebras) will gain 2-3 year leads on competitors relying on cloud APIs. For infrastructure teams, this signals: optimize for latency and cost, not just accuracy. By 2027, the winners will be companies that cached data, fine-tuned locally, and routed reasoning-grade queries to dedicated compute, not those throwing every query at generic LLM APIs.

Parsons Corporation announced on January 14, 2026, that it has acquired Altamira Technologies Corporation for up to $375 million. Altamira brings advanced analytics, signals intelligence (SIGINT), cyber, and space capabilities to Parsons' portfolio, strengthening its defense and intelligence offerings.

The defense tech signal: Defense contractors are consolidating AI and analytics capabilities. For defense CXOs and government agencies, this consolidation signals that AI-enabled intelligence (SIGINT, pattern recognition, threat detection) is now essential to competitive advantage. Companies that own proprietary defense AI will capture multi-billion dollar government contracts. For tech founders, defense AI is an underexplored greenfield with high barriers to entry and strong tailwinds from government spending.​

Google announced MedGemma 1.5 4B on January 15, 2026, a lightweight model fine-tuned specifically for healthcare. The model now supports high-dimensional 3D imaging (CT and MRI scans), longitudinal analysis (comparing current X-rays to prior images), and improved reasoning on medical records. Google also launched MedASR, an automated speech recognition model for medical dictation, achieving 82% fewer errors than leading generalist models on specialized benchmarks. The initiative includes a Kaggle Impact Challenge with $100,000 in prizes for healthcare AI applications.​

Why this matters: Domain-specific models are outperforming generalist LLMs on specialized tasks. For healthcare CXOs, this signals that deploying ChatGPT for clinical documentation is suboptimal, domain-tuned models will cut error rates by 3-4x while reducing hallucinations. For enterprise software vendors, this validates the "vertical AI agent" opportunity: every industry vertical will have domain-specific LLMs within 12-18 months. Winners will be companies that combine domain expertise with AI fine-tuning, not pure-play LLM vendors.

FDI Hits $51B in H1 FY26

National Startup Day 2026

Data Center Capacity to Hit 2GW by 2026

80% of Indian Startups Are AI‑Led

Apple, Samsung, ArcelorMittal Scale India Manufacturing

Digital Twin for Dedicated Freight Corridor

FDI in Insurance Raised to 100%

How India just became the world's most attractive manufacturing hub outside China.

On January 27, 2026, India and the European Union concluded the "mother of all deals", a comprehensive Free Trade Agreement that effectively fuses India's manufacturing ecosystem with Europe's $18 trillion consumer market, creating a combined $27 trillion trading bloc. Announced by Prime Minister Modi alongside EU Commission President Ursula von der Leyen and EU Council President António Costa, the agreement represents far more than tariff concessions. It signals to global manufacturers: India is the de-risked alternative to China, and it's legally binding for 15 years. For pharma, chemicals, steel, and automotive, this deal unlocks tariff certainty that has been absent from global supply chains since 2018.

The architecture is precise. Indian steel gets duty-free access (1.6 million tonnes annually, with ongoing negotiations to reach 3.2 million tonnes by June 2026). EU auto tariffs on Indian cars collapse from 110% to 10%, with parts tariffs fully eliminated over 5-10 years, directly threatening Chinese EV imports to Europe. Critically, India's services sector gains access to 144 EU subsectors spanning finance, maritime, telecommunications, and legal services. India opens 102 subsectors in return, creating a two-way services partnership that goes beyond typical trade deals. The framework includes a Most Favoured Nation (MFN) assurance on carbon pricing, meaning India won't bear discriminatory tariffs as Europe's carbon border adjustment mechanism unfolds, a protection worth billions to Indian steel and chemicals exporters.

For C-suite leaders planning 2026 supply chain strategy, this deal is a template shift: manufacturing nearness to end-markets now beats cost arbitrage. Before this, India was a cost play (labor, land). Today, it's a geopolitical hedge, tariff certainty, regulatory stability, and direct market access to Europe without China-complexity. Roche Pharma's ₹17,000 crore commitment on Day One of the EFTA agreement (October 2025) proved this thesis. Now the EU deal amplifies it: 18+ EFTA companies have signaled investment interest, and European manufacturers in chemicals, pharma, and precision engineering are fast-tracking India operations to serve Europe tariff-free. For Indian founders in B2B SaaS, manufacturing, and specialty chemicals, the next 12 months represent a capital inflow window that won't repeat if execution slips. The global capital confidence vote for India just went from "emerging market hedge" to "core manufacturing strategy."

Why it matters: When trade deals include 15-year tariff certainty, managed risk, and dual-market access, they don't just create commerce, they rewrite supply chains. India-EU creates exactly that. By 2028, the companies that positioned India operations now will have 2-3 year manufacturing leads on competitors still mired in China-complexity.

At GCCX, we turn “The India Opportunity” into your competitive advantage. While the world talks about talent arbitrage, we focus on talent amplification helping global founders build their core teams in India with insights, vetted talent, and seamless ops that just work.

Know founders exploring India teams? Connect them with us at [email protected]. You can also go to www.gccxglobal.com and join our growing network of change-makers turning macro trends into micro wins.